| Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY |
NEW YORK , May 15, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. |
prnewswire.com |
2025-05-15 21:06:00 |
Czytaj oryginał (ang.) |
| ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY |
NEW YORK, NY / ACCESS Newswire / May 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ:HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. SO WHAT: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. |
accessnewswire.com |
2025-05-14 22:00:00 |
Czytaj oryginał (ang.) |
| ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY |
NEW YORK CITY, NY / ACCESS Newswire / May 13, 2025 / WHY: New York, N.Y., May 13, 2025. |
accessnewswire.com |
2025-05-13 19:00:00 |
Czytaj oryginał (ang.) |
| Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY |
NEW YORK , May 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. |
prnewswire.com |
2025-05-12 19:55:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK CITY, NY / ACCESS Newswire / May 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-10 12:00:00 |
Czytaj oryginał (ang.) |
| ROSEN, SKILLED INVESTOR COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation – HQY |
NEW YORK, NY / ACCESS Newswire / May 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ:HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. SO WHAT: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. |
accessnewswire.com |
2025-05-10 01:45:00 |
Czytaj oryginał (ang.) |
| HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences |
DRAPER, Utah, May 09, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2026 financial results following the close of regular stock market trading hours on Tuesday, June 3, 2025. Following the news release, HealthEquity management plans to host a conference call for investors on Tuesday, June 3, 2025, at 4:30 p.m. Eastern Time during which management will review the Company's first quarter results. |
globenewswire.com |
2025-05-09 20:59:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. |
globenewswire.com |
2025-05-09 14:13:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-08 12:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-07 12:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK , May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
prnewswire.com |
2025-05-06 20:13:00 |
Czytaj oryginał (ang.) |
| If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights |
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. |
globenewswire.com |
2025-05-05 19:14:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. |
globenewswire.com |
2025-05-05 17:56:00 |
Czytaj oryginał (ang.) |
| MD vs. HQY: Which Stock Should Value Investors Buy Now? |
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2025-05-05 16:46:21 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK CITY, NY / ACCESS Newswire / May 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-03 14:00:00 |
Czytaj oryginał (ang.) |
| ROSEN, NATIONAL TRIAL COUNSEL, Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation – HQY |
NEW YORK, NY / ACCESS Newswire / May 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ:HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. SO WHAT: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. |
accessnewswire.com |
2025-05-03 01:33:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-02 14:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK, NY / ACCESS Newswire / May 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-01 14:00:00 |
Czytaj oryginał (ang.) |
| Rosen Law Firm Encourages HealthEquity, Inc. Investors to Inquire About Securities Class Action Investigation - HQY |
NEW YORK , April 30, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that HealthEquity may have issued materially misleading business information to the investing public. So What: If you purchased HealthEquity securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. |
prnewswire.com |
2025-04-30 22:32:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY |
NEW YORK, NY / ACCESS Newswire / April 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-04-30 16:15:00 |
Czytaj oryginał (ang.) |
| MD or HQY: Which Is the Better Value Stock Right Now? |
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors? |
zacks.com |
2025-02-27 14:40:21 |
Czytaj oryginał (ang.) |
| Here's Why HealthEquity (HQY) is a Strong Growth Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2025-02-27 12:50:48 |
Czytaj oryginał (ang.) |
| Forbes and U.S. News & World Report Agree: HealthEquity is One of America's Best Places to Work |
Forbes recognized HealthEquity as one of America's Dream Employers for 2025, while U.S. News & World Report named them one of the Best Companies to Work For in 2025 Forbes recognized HealthEquity as one of America's Dream Employers for 2025, while U.S. News & World Report named them one of the Best Companies to Work For in 2025 |
globenewswire.com |
2025-02-27 12:00:00 |
Czytaj oryginał (ang.) |
| The Path Forward: How Commuting Impacts the Return to Office Experience |
Commuting expenses are on employees' minds, and with more employees returning to the office, commuter benefits can ease the transition Commuting expenses are on employees' minds, and with more employees returning to the office, commuter benefits can ease the transition |
globenewswire.com |
2025-02-20 11:20:00 |
Czytaj oryginał (ang.) |
| HealthEquity Reports Year-End Sales Metrics |
Affirms Business Outlook, Announces Upcoming Events and Presentations Affirms Business Outlook, Announces Upcoming Events and Presentations |
globenewswire.com |
2025-02-18 18:01:00 |
Czytaj oryginał (ang.) |
| Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-02-07 12:46:12 |
Czytaj oryginał (ang.) |
| Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-01-28 12:50:18 |
Czytaj oryginał (ang.) |
| Tech-Powered Innovation Transforms Member Experiences and Earns HealthEquity Industry Recognition |
Awards acknowledge innovative approach that shows promise in making benefits simpler and faster to navigate Awards acknowledge innovative approach that shows promise in making benefits simpler and faster to navigate |
globenewswire.com |
2025-01-28 11:20:00 |
Czytaj oryginał (ang.) |
| HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference |
DRAPER, Utah, Jan. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation's largest health savings account (“HSA") custodian, today announced estimates of HSAs, HSA Assets and Total Accounts for its fiscal year ending January 31, 2025, reflecting a strong sales year with record New HSAs from Sales and strong custodial HSA Asset growth. |
globenewswire.com |
2025-01-13 11:01:00 |
Czytaj oryginał (ang.) |
| Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now |
HQY's sustained strength in HSAs raises optimism about the stock. |
zacks.com |
2025-01-10 10:45:57 |
Czytaj oryginał (ang.) |
| Why Is HealthEquity (HQY) Up 3.5% Since Last Earnings Report? |
HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? |
zacks.com |
2025-01-08 14:30:31 |
Czytaj oryginał (ang.) |
| HealthEquity Gains 46.8% in a Year: What's Driving the Stock? |
HQY's sustained strength in HSAs raises optimism about the stock. |
zacks.com |
2024-12-27 13:01:11 |
Czytaj oryginał (ang.) |
| PACS or HQY: Which Is the Better Value Stock Right Now? |
Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now? |
zacks.com |
2024-12-25 14:41:12 |
Czytaj oryginał (ang.) |
| Here's Why HealthEquity (HQY) is a Strong Growth Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-12-17 12:45:39 |
Czytaj oryginał (ang.) |
| HealthEquity Caps 2024 With Widespread Recognition For Its Workplace Excellence |
Honored nationally and across nine states, HealthEquity's culture of innovation, flexibility, and inclusion set a standard for being a place where people want to work Honored nationally and across nine states, HealthEquity's culture of innovation, flexibility, and inclusion set a standard for being a place where people want to work |
globenewswire.com |
2024-12-17 11:20:00 |
Czytaj oryginał (ang.) |
| HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat |
HQY's fiscal third-quarter results benefit from robust HSA growth and improved gross margin. It also raises fiscal 2025 guidance. |
zacks.com |
2024-12-10 14:11:21 |
Czytaj oryginał (ang.) |
| HealthEquity Stock Falls on Disappointing Outlook |
Shares of HealthEquity (HQY) tumbled Tuesday after the health savings account (HSA) custodian's full-year outlook missed forecasts. |
investopedia.com |
2024-12-10 13:55:44 |
Czytaj oryginał (ang.) |
| HealthEquity, Inc. (HQY) Q3 2025 Earnings Call Transcript |
HealthEquity, Inc. (NASDAQ:HQY ) Q3 2025 Earnings Conference Call December 9, 2024 4:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President and CEO James Lucania - EVP and CFO Steve Neeleman - Vice Chair and Founder Scott Cutler - upcoming President and CEO Conference Call Participants Gregory Peters - Raymond James Stan Berenshteyn - Wells Fargo Glen Santangelo - Jefferies Allen Lutz - Bank of America Anne Samuel - JPMorgan George Hill - Deutsche Bank Mark Marcon - Baird David Roman - Goldman Sachs David Larsen - BTIG Steven Valiquette - Mizuho Securities Sean Dodge - RBC Capital Markets Operator Good afternoon, and welcome to the HealthEquity Third Quarter 2025 Earnings Conference Call. Please note this event is being recorded. |
seekingalpha.com |
2024-12-10 02:08:35 |
Czytaj oryginał (ang.) |
| HealthEquity (HQY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates |
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2024-12-09 20:30:15 |
Czytaj oryginał (ang.) |
| HealthEquity (HQY) Beats Q3 Earnings and Revenue Estimates |
HealthEquity (HQY) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.60 per share a year ago. |
zacks.com |
2024-12-09 20:16:07 |
Czytaj oryginał (ang.) |
| HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results |
Highlights of the third quarter include: Revenue of $300.4 million, an increase of 21% compared to $249.2 million in Q3 FY24. Net income of $5.7 million, compared to $14.7 million in Q3 FY24, with non-GAAP net income of $69.4 million, an increase of 33% compared to $52.2 million in Q3 FY24. |
globenewswire.com |
2024-12-09 18:01:00 |
Czytaj oryginał (ang.) |
| North American Morning Briefing : Global Ad Shares -2- |
Lundin Mining Announces Sale to Boliden of its Neves-Corvo operation in Portugal and Zinkgruvan operation in Sweden for Up to $1.52 Billion: Lundin To Receive Upfront Cash Consideration of $1.37B Upon Closing; To Also Get up to $150M in Contingent Cash Upon Satisfaction of Condition; Proceeds Will Strengthen Balance Sheet and Support Growth Plans in the Vicuña District Expected Major Events for Monday aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); 00:01/UK: Nov KPMG and REC UK Report on Jobs 04:30/JPN: Nov Corporate Insolvencies 05:00/JPN: Nov Economy Watchers Survey 07:00/GER: 3Q Labour cost index 15:00/US: Oct Monthly Wholesale Trade 15:00/US: Nov Employment Trends Index 23:50/JPN: Nov Money Stock, Broadly-defined Liquidity All times in GMT. Powered by Kantar Media and Dow Jones. Expected Earnings for Monday Amtech Systems Inc (ASYS) is expected to report $-0.01 for 4Q. Anavex Life Sciences Corp (AVXL) is expected to report $-0.16 for 4Q. Avalon Advanced Materials is expected to report for 4Q. Braze Inc (BRZE) is expected to report $-0.30 for 3Q. Buckle Inc (BKE) is expected to report. C3.ai Inc (AI) is expected to report $-0.60 for 2Q. Casey's General Stores Inc (CASY) is expected to report $4.25 for 2Q. Centene Corp (CNC) is expected to report for Full year. Digital Ally Inc (DGLY) is expected to report for 3Q. Franklin Resources Inc (BEN) is expected to report. Genasys Inc (GNSS) is expected to report $-0.11 for 4Q. Healthequity Inc (HQY) is expected to report $0.24 for 3Q. MongoDB Inc (MDB) is expected to report $-0.83 for 3Q. NexPoint Diversified Real Estate Trust (NXDT) is expected to report for 3Q. North West Co Inc (NWC.T) is expected to report $0.77 for 3Q. Oil-Dri Corp of America (ODC) is expected to report for 1Q. Oracle Corp (ORCL) is expected to report $1.06 for 2Q. Phreesia Inc (PHR) is expected to report $-0.27 for 3Q. Planet Labs PBC (PL) is expected to report $-0.08 for 3Q. Remark Holdings Inc (MARK) is expected to report $-0.19 for 3Q. Rent the Runway Inc (RENT) is expected to report for 3Q. Smart Share Global Ltd - ADR (EM) is expected to report for 3Q. Talis Biomedical Corp (TLIS) is expected to report for 3Q. Titan Pharmaceuticals Inc (TTNP) is expected to report for 3Q. Toll Brothers Inc (TOL) is expected to report $4.34 for 4Q. Vail Resorts (MTN) is expected to report $-4.96 for 1Q. VersaBank is expected to report $0.29 for 4Q. Webco Industries Inc (WEBC) is expected to report for 1Q. Yext Inc (YEXT) is expected to report $0.06 for 3Q. Powered by Kantar Media and Dow Jones. ANALYST RATINGS ACTIONS Altria Raised to Buy From Neutral by B of A Securities Argan Cut to Market Perform From Market Outperform by CJS Securities Asana Raised to Sector Weight From Underweight by Keybanc Brixmor Property Group Raised to Outperform From Market Perform by BMO Capital Deere & Co Cut to Hold From Buy by Jefferies DocuSign Cut to Reduce From Hold by HSBC Dollar General Raised to Buy From Underperform by B of A Securities Duckhorn Portfolio Cut to Hold From Buy by Jefferies EPAM Systems Raised to Buy From Neutral by Goldman Sachs Fortrea Holdings Cut to Neutral From Outperform by Baird GrafTech International Raised to Neutral From Underweight by JP Morgan Hewlett Packard Ent Raised to Buy From Neutral by Citigroup Kennametal Cut to Hold From Buy by Jefferies Molson Coors Beverage Raised to Buy From Neutral by B of A Securities ONE Gas Cut to Neutral From Buy by Ladenburg Thalmann Paccar Cut to Hold From Buy by Jefferies Peloton Interactive Raised to Neutral From Sell by UBS PJT Partners Raised to Neutral From Sell by UBS PotlatchDeltic Raised to Outperform From Market Perform by BMO Capital ProFrac Holding Cut to Underweight From Neutral by JP Morgan Prologis Cut to Underperform From Market Perform by BMO Capital ProPetro Holding Raised to Neutral From Underweight by JP Morgan Republic Services Raised to Outperform From Market Perform by BMO Capital Robinhood Markets Raised to Buy From Neutral by Goldman Sachs SiteOne Landscape Supply Raised to Buy From Hold by Jefferies Smith & Wesson Brands Cut to Hold From Buy by Craig-Hallum Smith & Wesson Brands Cut to Hold From Buy by Lake Street Timken Raised to Buy From Hold by Jefferies WesBanco Raised to Strong Buy From Outperform by Raymond James Weyerhaeuser Raised to Outperform From Market Perform by BMO Capital This article is a text version of a Wall Street Journal newsletter published earlier today. (END) Dow Jones Newswires 12-09-24 0634ET |
https://www.marketscreener.com |
2024-12-09 08:35:38 |
Czytaj oryginał (ang.) |
| Unlocking Q3 Potential of HealthEquity (HQY): Exploring Wall Street Estimates for Key Metrics |
Beyond analysts' top -and-bottom-line estimates for HealthEquity (HQY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2024. |
zacks.com |
2024-12-06 12:17:14 |
Czytaj oryginał (ang.) |
| HealthEquity 2025 Benefits Trends Unveiled: Cost Transparency and Containment Take Center Stage for Administrators |
SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization SHRM-hosted event will focus on tactics and takeaways to help employers combat rising costs that affect employee satisfaction and benefits utilization |
globenewswire.com |
2024-12-03 11:20:00 |
Czytaj oryginał (ang.) |
| HealthEquity, Inc. (HQY) Hit a 52 Week High, Can the Run Continue? |
HealthEquity (HQY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. |
zacks.com |
2024-11-25 12:15:22 |
Czytaj oryginał (ang.) |
| Investment Committee Moves: EPAM, Paycom, Blackstone, Healthequity, Booz Allen, Leidos, and Vertiv |
Karen Firestone and Steve Weiss join CNBC's 'Halftime Report' to detail their latest portfolio moves. |
youtube.com |
2024-11-21 16:18:25 |
Czytaj oryginał (ang.) |
| HealthEquity Gains 54.6% YTD: What's Driving the Stock? |
HQY's sustained strength in HSAs raises optimism about the stock. |
zacks.com |
2024-11-20 14:06:26 |
Czytaj oryginał (ang.) |
| HealthEquity: High Marks For Recent Profit Growth |
HealthEquity's future growth relies heavily on capital reinvestment due to the asset-light nature of the business. High multiples of capital are necessary to ensure each $1 of retained and reinvested earnings is valued highly by the market. The core asset base has hard-to-replicate business advantages that have grown operating earnings at attractive rates which by all means can continue. |
seekingalpha.com |
2024-11-20 07:16:50 |
Czytaj oryginał (ang.) |
| Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-11-19 12:45:21 |
Czytaj oryginał (ang.) |
| HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards |
Award recognizes Padia's vision to bring client and member experiences to life through an innovative, immersive experience Award recognizes Padia's vision to bring client and member experiences to life through an innovative, immersive experience |
globenewswire.com |
2024-11-19 11:20:00 |
Czytaj oryginał (ang.) |
| Strength Seen in HealthEquity (HQY): Can Its 3.5% Jump Turn into More Strength? |
HealthEquity (HQY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
zacks.com |
2024-11-19 08:01:25 |
Czytaj oryginał (ang.) |